357 related articles for article (PubMed ID: 19660809)
21. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
Kim JE; Park YJ
Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
23. Efficient Codelivery of Paclitaxel and Curcumin by Novel Bottlebrush Copolymer-based Micelles.
Yao Q; Gutierrez DC; Hoang NH; Kim D; Wang R; Hobbs C; Zhu L
Mol Pharm; 2017 Jul; 14(7):2378-2389. PubMed ID: 28605595
[TBL] [Abstract][Full Text] [Related]
24. Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.
Huang W; Wang X; Shi C; Guo D; Xu G; Wang L; Bodman A; Luo J
Mol Pharm; 2015 Apr; 12(4):1216-29. PubMed ID: 25692376
[TBL] [Abstract][Full Text] [Related]
25. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
26. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
27. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
28. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel.
Zhang P; Huang Y; Liu H; Marquez RT; Lu J; Zhao W; Zhang X; Gao X; Li J; Venkataramanan R; Xu L; Li S
Biomaterials; 2014 Aug; 35(25):7146-56. PubMed ID: 24856103
[TBL] [Abstract][Full Text] [Related]
29. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
30. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
31. A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models.
Bhattacharyya J; Bellucci JJ; Weitzhandler I; McDaniel JR; Spasojevic I; Li X; Lin CC; Chi JT; Chilkoti A
Nat Commun; 2015 Aug; 6():7939. PubMed ID: 26239362
[TBL] [Abstract][Full Text] [Related]
32. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
33. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
Huang G; Zang B; Wang X; Liu G; Zhao J
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):981-7. PubMed ID: 26525950
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.
Zhang R; Luo K; Yang J; Sima M; Sun Y; Janát-Amsbury MM; Kopeček J
J Control Release; 2013 Feb; 166(1):66-74. PubMed ID: 23262201
[TBL] [Abstract][Full Text] [Related]
35. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
36. PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.
Shu X; Zhu Z; Cao D; Zheng L; Wang F; Pei H; Wen J; Yang J; Li D; Bai P; Tang M; Ye H; Peng A; Li W; Chen L
Colloids Surf B Biointerfaces; 2019 Oct; 182():110356. PubMed ID: 31319226
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape.
Zhao H; Li Q; Hong Z
Mol Pharm; 2016 Jul; 13(7):2411-22. PubMed ID: 27266442
[TBL] [Abstract][Full Text] [Related]
38. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
[TBL] [Abstract][Full Text] [Related]
39. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
[TBL] [Abstract][Full Text] [Related]
40. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel.
Wang C; Wang Y; Wang Y; Fan M; Luo F; Qian Z
Int J Pharm; 2011 Jul; 414(1-2):251-9. PubMed ID: 21596124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
